Targeted ultrasonic contrast agents for molecular imaging and therapy: A brief review

MedicaMundi

Volumn 47, Issue 1, 2003, Pages 66-73

  Hughes, M S ^a   Lanza, G M ^a   Marsh, J N ^a   Wickline, S A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21644488215     PISSN: 00257664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (63)

1. Katz J. Pharmaceutical Discovery and Development: Nuclear and Molecular Imaging Technologies Recognized. J Nucl Med 1999; 40, 7: 22N-23N, 26N.2.
2. Lanza G et al. Enhanced Detection of Thrombi With a Novel Fibrin-Targeted Magnetic Resonance Imaging Agent. Acad Radiol 1998; 5 (Suppl 1): S173-S176.
3. Gupta H, Weissleder R. Targeted Contrast Agents in MR Imaging. Magn Reson Imag Clinics N Am 1996; 4: 171-184.
4. Weissleder R et al. MR Receptor Imaging: Ultrasmall Iron Oxide Particles Targeted to Asialoglycoprotein Receptors. AJR 1990; 155,6: 1161-1167.
5. Gramiak R, Shah PM. Echocardiography of the Aortic Root. Investigative Radiology 1968; 3: 356-366.
6. Porter T et al. Interaction of Diagnostic Ultrasound with Synthetic Oligonucleotide-Labeled Perfluoro-carbon-Exposed Sonicated Dextrose Albumin Microbubbles. J Ultrasound Med 1996; 15,8: 577-584.
7. Klibanov AL et al. Targeting of Ultrasound Contrast Material. An In Vitro Feasibility Study. Acta Radiologica Suppl 1997; 412: 113-120.
8. Unger E et al. In Vitro Studies of a New Thrombus-Specific Ultrasound Contrast Agent. Am J Cardiol 1998; 81: 58G-61G.
9. Christopher D et al. A High-Frequency Continuous-Wave Doppler Ultrasound System for the Detection of Blood Flow in the Microcirculation. Ultrasound Med Biol 1996; 22,9: 1191-1203.
10. Lanza G et al. A Novel Site-Targeted Ultrasonic Contrast Agent with Broad Biomedical Application. Circulation 1996; 94: 3334-3340.
11. Demos S et al. In Vitro Targeting of Antibody-Conjugated Echogenic Liposomes for Site-Specific Ultrasonic Image Enhancement. J Pharm Sci 1997; 86,2: 161-171.
12. Moghimi S, Patel H. Serum Opsonins and Phagocytosis of Saturated and Unsaturated Phospholipid Liposomes. Biochim Biophys Acta, 1989; 984 (3): P. 384-7.13.
13. Moghimi S and Patel H. Differential Properties of Organ-Specific Serum Opsonins for Liver and Spleen Macrophages. Biochim Biophys Acta 1989; 984, 3: 379-383.
14. Unger E et al. Gas-Filled Liposomes as Echocardiographic Contrast Agents in Rabbits with Myocardial Infarcts. Invest Radiol 1993; 28,12: 1155-1159.
15. Unger E et al. Acoustically Active Lipospheres Containing Paclitaxel: A New Therapeutic Ultrasound Contrast Agent. Invest Radiol 1998; 33,12: 886-892.
16. Unger EC, McCreery TP, Sweitzer RH. Ultrasound Enhances Gene Expression of Liposomal Transfection. Invest Radiol 1997; 32: 723-727.
17. Price R et al. Delivery of Colloidal Particles and Red Blood Cells to Tissue through Microvessel Ruptures Created by Targeted Microbubble Destruction with Ultrasound. Circulation 1998; 98: 1264-1267.
18. Paganelli G et al. Three-Step Monoclonal Antibody Tumor Targeting in Carcinoembryonic Antigen-Positive Patients. Cancer Res 1991; 51: 5960-5966.
19. Dosio F et al. Three-Step Tumor Pre-Targeting in Lung Cancer Immunoscintigraphy. J Nucl Biol Med 1993; 37: 228-232.
20. Modorati G et al. Immunoscintigraphy with Three Step Monoclonal Pretargeting Technique in Diagnosis of Uveal Melanoma: Preliminary Results. Br J Opthalmol 1994; 78: 19-23.
21. Kaseda N et al. Induction of In Situ Immune Complexes in Rat Glomeruli using Avidin, Native Cation Macromolecule. Br J Exp Pathol, 1985; 66,6: 729-735.
22. De Bruin R et al. Selection of High-Affinity Phage Antibodies from Phage Display Libraries. Nat Biotechnol 1999; 17,4: 397-399.
23. Stadler B. Antibody Production without Animals. Dev Biol Stand 1999. 101: 45-48.
24. Wittrup K. Phage on Display. Trends Biotechnol 1999; 17,11: 423-424.
25. Sche P et al. Display Cloning: Functional Identification of Natural Product Receptors Using cDNA-Phage Display. Chem Biol 1999; 6,10: 707-716.
26. Wright WJ et al. Evaluation of New Thrombus-Specific Ultrasound Contrast Agent. Acad Radiol 1998; 5 (Suppl 1): S240-S242.
27. Reimer P et al. Pancreatic Receptors: Initial Feasibility Studies with a Targeted Contrast Agent for MR Imaging. Radiology 1994; 193,2: 527-531.
28. Reimer P, Bader A, Weissleder R. Preclinical Assessment of Hepatocyte-Targeted MR Contrast Agents in Stable Human Liver Cell Cultures. J Magn Reson Imaging 1998; 8,3: 87-89.
29. Leveille-Webster C, Rogers J, Arias I. Use of an Asialoglycoprotein Receptor-Targeted Magnetic Resonance Contrast Agent to Study Changes in Receptor Biology during Liver Regeneration and Endotoxemia in Rats. Hepatology 1996; 23,6: 1631-1641.
30. Reimer P et al. Dynamic Signal Intensity Changes in Liver with Superparamagnetic MR Contrast Agents. J Magn Reson Imaging 1992; 2,2: 177-181.
31. Reimer P et al. Receptor-Directed Contrast Agents for MR Imaging: Preclinical Evaluation with Affinity Assays. Radiology 1992; 182,2: 565-569.
32. Small W et al. Enhancement Effects of a Hepatocyte Receptor-Specific MR Contrast Agent in an Animal Model. J Magn Reson Imaging 1994; 4,3: 325-330.
33. Unger E et al. Nitrogen-Filled Liposomes as a Vascular US Contrast Agent: Preliminary Evaluation. Radiology 1992; 185, 453-456.
34. Unger E et al. Gas-Filled Lipid Bilayers as Ultrasound Contrast Agents. Invest Radiol 1994; 29: S134-S136.
35. Unger E, Matsunaga TO, Schumann PA, Zutshi R. Microbubbles in Molecular Imaging and Therapy. Medicamundi 2003; 47,1: 58-65.
36. Klibanov A et al. Targeting of Ultrasound Contrast Material: An In Vitro Feasibility Study. Acta Radiol 1997; 412 (Suppl 1): 113-120.
37. Villanueva FS et al. Microbubbles Targeted to Intracellular Adhesion Molecule-1 Bind to Activated Coronary Artery Endothelial Cells. Circulation 1998; 98: 1-5.
38. Dayton et al. Acoustic Radiation Force In Vivo: A Mechanism to Assist Targeting of Microbubbles. Ultrasound Med Biol 1999; 25: 1195-1201.
39. Klibanov A et al. Targeting and Ultrasound Imaging of Microbubble-Based Contrast Agents. Magma 1999; 8,3: 177-184.
40. New R et al. Antileishmanial Activity of Antimonials Entrapped in Liposomes. Nature 1978; 272 (5648): 55-56.
41. Alving C et al. Therapy of Leishmaniasis: Superior Efficacies of Liposome-Encapsulated Drugs. Proc Natl Acad Sci 1978; 75,6: 2959-2963.
42. Wassef N et al. Suppression of Phagocytic Function and Phospholipid Metabolism in Macrophages by Phosphatidylinositol Liposomes. Proc Natl Acad Sci 1984; 81,9: 2655-2659.
43. Porter T et al. Enhanced Delivery and Effectiveness of Antisense Oligonucleotides when Bound to Intravenous Perfluorocarbon-Filled Microbubbles: Effect of Ultrasound and Therapeutic Implications. J Am Soc Echocardiogr 1997; 10: 413.
44. Shi Y et al. Transcatheter Delivery of c-myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury. Circulation 1994; 90,2: 944-951.
45. Hiser W et al. Inhibition of Carotid Artery Neointimal Formation following Balloon Injury using Ultrasound-Targeted Deposition of Antisense to C-MYC Protooncogene Bound to Intravenously Delivered Perfluorocarbon Microbubbles. J Am Soc Echocardiogr 1998; 11: 498.
46. Porter T et al. Detrimental Effects of Low Frequency 20 Kilohertz Transthoracic Ultrasound On Coronary Artery Neointimal Hyperplasia Following Balloon Injury: 30 day Angiographic Histologic and Ultrasound Intravascular Observations. J Am Soc Echocardiogr 1999; 12: 399.
47. Porter T et al. Intravenous Antisense Administered Bound to Perfluorocarbon Exposed Sonicated Dextrose Albumin Microbubbles Inhibits Stenosis Formation following Coronary Balloon Injury. Circulation 1999; 100 (Suppl 1): I-71.
48. Alkan-Onyuksel H et al. Development of Inherently Echogenic Liposomes as an Ultrasonic Contrast Agent. J Pharm Sci 1996; 85,5: 486-490.
49. Demos S et al. In Vivo Targeting of Acoustically Reflective Liposomes for Intravascular and Transvascular Ultrasonic Enhancement. J Am Coll Cardiol 1999; 33,3: 867-875.
50. Tiukinhoy S et al. Development of Inherently Acoustic Plasmid-Incorporated Tissue-Targeted Cationic Liposomes for Directed Gene Delivery. J Clin Invest 2000 (in Press).
51. Lanza GM, Wickline SA. Targeted Ultrasonic Contrast Agents for Molecular Imaging and Therapy. Progress in Cardiovascular Diseases 2001; 44,1: 13-31.
52. Lanza G et al. In Vitro Characterization of a Novel Tissue-Targeted Ultrasonic Contrast System with Acoustic Microscopy. J Acoust Soc Am 1998; 104,6: 3665-3672.
53. Hall CS et al. Experimental Determination of Phase Velocity of Perfluorocarbons: Applications to Targeted Contrast Agent. In: Proc. IEEE Ultrasonics Symposium; 1997.
54. Marsh JN et al. Manipulation of Backscatter Enhancement from Targeted Nanoparticle Emulsion Contrast Agent by Incorporation of Perfluorocarbons with Varying Acoustic Impedance. J Soc Photo-Optical Instr Engineers 2000 (in Press).
55. Broze GJ et al. Purification of Human Brain Tissue Factor. J Biol Chem 1985; 260,20: 10917-10920.
56. Scarpati E et al. Human Tissue Factor: cDNA Sequence and Chromosome Localization of the Gene. Biochemistry 1987; 26,17: 5234-5238.
57. Lanza GM et al. In Vivo Molecular Imaging of Stretch-Induced Tissue Factor in Carotid Arteries With Ligand-Targeted Nanoparticles. J Am Soc Echo 2000; 13,6: 608-614.
58. Lanza G et al. Molecular Imaging of Stretch-Induced Tissue Factor Expression in Carotid Arteries with Intravascular Ultrasound. Invest Radiol 2000; 35: 227-234.
59. St Pierre J et al. Tissue Factor Pathway Inhibitor Attenuates Procoagulant Activity and Upregulation of Tissue Factor at the Site of Balloon-Injured Arteries in Pigs. Thromb Vasc Biol 1999; 19: 2263-2268.
60. Marmur J et al. Tissue Factor is Rapidly Induced in Arterial Smooth Muscle after Balloon Injury. J Clin Invest 1993; 91,5: 2253-2259.
61. Oltrona L et al. Inhibition of Tissue Factor-Mediated Coagulation Markedly Attenuates Stenosis after Balloon-Induced Arterial Injury in Minipigs. Circulation 1997; 96 (2): 646-652.
62. Lanza GM, Lamerichs R, Caruthers S, Wickline SA. Molecular Imaging in MR with Targeted Paramagnetic Nanoparticles. Medicamundi 2003; 47,1: 34-39.
63. Xin Y et al. Molecular Characterization of Thrombus using Bimodal 1H/19F MR Imaging with a Novel Fibrin-Targeted Nanoparticulate Contrast Agent. In: 8th Scientific Meeting of the ISMRM Denver 2000.